CA 19-9 Tumor Marker: Is It Reliable? A Case Report In A Patient …

Since the original diagnosis, the patient had fluctuating CA 19-9 levels with no significant clinical symptoms and negative staging positron emission tomography (PET) and CT scans. Aggressive chemotherapy with erlotinib (Tarceva, Genentech/Roche) was administered to prevent biochemical relapse of CA 19-9 and the development of metastasis.

Actived: Thursday Jan 1, 1970

View Details Hematologyandoncology.net